)
Fluicell (FLUI) investor relations material
Fluicell Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved the strongest revenue quarter in company history, with Q2 net sales up 934% year-over-year and five consecutive quarters of increasing net sales.
Strategic progress with successful project milestones in diabetes and cancer collaborations, and strengthened board with new commercial expertise.
AI integration implemented across all projects, enhancing screening solutions and data analysis.
Financial highlights
Q2 2026 net sales: 7,277 KSEK (704 KSEK in Q2 2025), total operating income: 8,701 KSEK (3,541 KSEK).
EBITDA for Q2: 2,314 KSEK (-2,734 KSEK), EBIT: 2,239 KSEK (-2,824 KSEK), net income: 2,260 KSEK (-2,887 KSEK).
H1 2026 net sales: 13,372 KSEK (934 KSEK in H1 2025), EBITDA: 5,693 KSEK (-5,274 KSEK), EBIT: 5,531 KSEK (-5,468 KSEK), net income: 5,570 KSEK (-5,562 KSEK).
EPS Q2: 1.65 SEK (-2.10 SEK), H1: 4.05 SEK (-4.05 SEK).
Cash flow from operations Q2: -2,092 KSEK (-2,879 KSEK), H1: -1,844 KSEK (-6,672 KSEK).
Outlook and guidance
Focus for the remainder of 2026 is on broadening revenue streams and strengthening liquidity, with commercialization of advanced cardiac tissue models as a key path.
Management expects continued positive momentum, supported by new board expertise and ongoing innovation.
Full-year 2026 result and cash flow forecasted between -1 MSEK and +1 MSEK.
- Record revenue and profit growth in Q1 2026, driven by technology and medical partnerships.FLUI
Q1 2026 - Record Q4 sales and positive cash flow signal a strong turnaround and strategic progress.FLUI
Q4 2025 - Q3 net sales surged 138% year-over-year, with 2026 guidance indicating near break-even.FLUI
Q3 2025 - Revenues surged and losses narrowed, but new financing is needed to sustain operations.FLUI
Q2 2025 - Q3 revenue surged 93% and losses narrowed, but external funding remains essential.FLUI
Q3 2024 - Revenue fell on strategic refocus, but cost savings and new capital support future growth.FLUI
Q2 2024 - Operating loss narrows as Fluicell advances regenerative medicine and diabetes therapy.FLUI
Q1 2025 - Strategic shift and capital raises drove improved results and growth in tissue-based therapies.FLUI
Q4 2024
Next Fluicell earnings date
Next Fluicell earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)